Vertex Pharmaceuticals(VRTX)
Focus: Vertex is a Boston-based biotech leader with 10,400 employees focused on cystic fibrosis, rare diseases, pain, and sickle cell disease. The company generates $9.9B in annual revenue with a highly concentrated commercial profile.
Profile data last refreshed 9h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Employees
10,400
Open Jobs
269+154 this month
Hot — 457 jobs added in 30d
Net +154 (457 new, 303 removed). Aggressive expansion phase.
Should You Work at Vertex Pharmaceuticals?
AI assessmentVertex is a stable, well-capitalized biotech with a dominant CF franchise and robust hiring, but career longevity depends on pipeline diversification beyond rare diseases.
Why Work Here
- Strong financial performance ($9.9B FY2025 revenue, $3.6B net income, $10.5B cash) provides stability and investment in R&D ($3.2B).
- Market-leading CF franchise (KALYDECO, ORKAMBI, TRIKAFTA, SYMDEKO, ALYFTREK) with extended patent protection through 2043 offers deep domain expertise.
Data completeness
7/9 — Strong
Company HealthSolid
Pipeline
Early-stage
50 total
LOE Risk
1 imminent
INCIVEK
Hiring
Stable
Revenue
$9.9B
FY2025
Key Products
$25M Part DStable
Peak6.9yr
Flagship product generating majority of company revenue; remains in peak sales phase with extended patent protection.
Help build intelligence for Vertex Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.